





Oxidative Stress and Aging 
 
How does aging occur? Can we delay the aging 
process? These are questions that have been asked for 
hundreds if not thousands of years. Many hypotheses 
have been proposed, but the majority of them have 
failed to stand up to further scrutiny. In 1956, Harman 
proposed the oxidative stress theory of aging, which has 
gained great popularity among aging researchers [1]. It 
postulates that the production of reactive oxygen 
species (ROS) is the major determinant of lifespan. 
ROS can be produced in multiple compartments within 
cells, but mitochondria account for over 90% of ROS 
generation [2]. Counteracting cellular ROS are anti-
oxidant enzymes such as superoxide dismutases 
(SODs). The level of cellular ROS is determined by the 
balance between the generation of ROS and its 
detoxification. 
 
  The oxidative stress theory is supported by the 
observation that the levels of oxidative stress and 
damage increase with age in a wide variety of animal 
models [3]. Also, longer-lived animals tend to have 
reduced oxidative damage and/or increased resistance to 
oxidative stress. However, under experimental settings, 
the theory has met with some difficulties. Studies in 
mice where the expressions of  antioxidant  enzymes    
are  genetically  modified  call  into serious question  the  
 
 


























oxidative stress theory of aging [4]. Although deleting 
the antioxidant genes has deleterious effects, surpri-
singly, under or overexpressing a number of genes 
encoding antioxidants mostly has no effect on lifespan. 
Even mice that are transgenic for SOD2, a crucial 
mitochondrial antioxidant, do not show an increase in 
lifespan. Is the connection between oxidative stress and 
lifespan simply a coincidence? Is it time to throw away 
the oxidative stress theory of aging? 
 
A potential explanation for this controversy has 
emerged from recent studies on the mammalian 
mitochondrial deacetylase SIRT3. Endogenous SOD2 is 
modified by acetylation. By deacetylating specific 
lysine residues on SOD2, SIRT3 improves the ability of 
SOD2 to scavenge for ROS [5,6]. Interestingly, 
increasing SOD2 expression alone only modestly 
reduces cellular ROS. However, when SOD2 over-
expression is combined with SIRT3 overexpression, the 
reduction in cellular ROS is much greater. These 
observations suggest that only altering SOD2 
expression is insufficient to significantly reduce cellular 
oxidative stress, and that it needs to be modified by 
deacetylation to operate at peak activity. In addition to 
SOD2, a number of antioxidants such as SOD1 and 
glutathione peroxidase have been shown to be acetyl-
ated [7]. It is possible that these antioxidants are also 
regulated via deacetylation. 
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Perhaps the oxidative stress theory of aging has not 
been given a fair trial. These latest findings suggest that 
future tests of the theory need to take into account not 
only the expression level of antioxidants, but their 
activity level as well. In the case of SOD2, generating 
SOD2 transgenic mice is not enough, as SOD2 requires 
SIRT3 to become fully active. Thus, an interesting and 
pivotal test of the oxidative stress theory of aging will 
be whether mice that are transgenic for both SOD2 and 
SIRT3 have extended lifespans. In addition to having 
major implications for the oxidative stress theory of 
aging, the latest findings connecting SIRT3 and 
oxidative stress have also provided illumination to long-
standing questions regarding calorie restriction (CR) 
and may lead to a novel way of treating cancer.   
 
SIRT3: a Missing Link between Calorie Restriction 
and the Oxidative Stress Response  
 
CR is one of the most robust interventions to 
consistently extend lifespan across species [8-10]. In 
mammals, this dietary regimen also results in salutary 
physiological changes and ameliorates a wide spectrum 
of diseases associated with aging. CR substantially 
reduces the steady state levels of oxidative stress and 
damage. Ostensibly, CR could slow the metabolic rate 
and reduce the production of ROS. However, despite 
the attractive simplicity of this hypothesis, it does not 
stand up to experimental scrutiny. Increasing evidence 
suggests that metabolic rate does not decrease during 
CR, and in some cases, even increases [11,12]. How is 
CR able to reduce oxidative stress without lowering 
metabolic rate? Does CR accomplish this feat by 
regulating defined molecular pathways? And, import-
antly, is lowered oxidative stress essential for the 
beneficial effects of CR? The recent work in SIRT3 has 
led to great strides in answering these questions.  
 
Sirtuins have long been associated with CR in model 
organisms, so it is not surprising that this family of 
proteins was found to play a pivotal role in addressing 
the questions [13]. Previously, it had been found that 
the mammalian sirtuin SIRT1 is required to mediate 
aspects of the CR response in mice [14,15]. However, it 
is only with the work of Qiu et al. (2010) and Someya 
et al. (2010) that a solid connection between oxidative 
stress and sirtuins in the CR response was made [5,16]. 
Taking the spotlight away from SIRT1, SIRT3 was 
found to be essential for CR-mediated reduction in 
oxidative stress. Qiu et al. (2010) showed that the 
reduction in oxidative stress during CR was abolished in 
SIRT3-/- mice. As mentioned above, one mechanism 
through which SIRT3 reduces oxidative stress is by 
increasing the activity of SOD2 through deacetylation 
[5,6]. In addition to regulating SOD2, SIRT3 also 
reduces oxidative stress by modulating the activity of 
isocitrate dehydrogenase 2 (IDH2), a mitochondrial 
enzyme that generates the reducing agent NADPH [16]. 
Thus, instead of passively slowing metabolic rate, CR 
induces an active defense program to increase the rate at 
which destructive oxidizing agents are scavenged, with 
SIRT3 playing an essential role (Figure 1).  
 
  Does the reduction of oxidative stress have any 
physiological relevance with regards to the benefits of 
CR? Hearing loss is a hallmark of aging, and has been 
shown to be delayed in mice by CR. Someya et al. 
(2010) showed that the protective effect of CR on 
hearing loss requires reduction in oxidative stress 
mediated by SIRT3 [16]. When SIRT3-/- mice are 
placed on CR, not only is oxidative stress not reduced, 
but the protection against hearing loss with age is 
abolished as well. It was also recently shown that 
SIRT3 is important for protecting the heart against 
aging-induced hypertrophy and fibrosis, but oxidative 
stress has not been directly implicated [17]. It will be 
interesting to see if other benefits of CR can be linked 
to SIRT3 and oxidative stress. 
 
  Figure 1. Calorie restriction activates SIRT3 to reduce 
oxidative  stress  and  combat  aging.  Calorie  restriction 
promotes the activity of SIRT3, which deacetylates SOD2 
and  IDH2,  increasing  the  activity  of  these  enzymes  and 
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Aging is a multifaceted degenerative process leading to 
tissue functional decline and increased incidence of 
cancer. One important mechanism central to aging is 
cumulative cellular damage, prominently DNA damage 
[18]. In response to DNA damage, gate-keeping tumor 
suppressor proteins such as p53 are activated to ensure 
that potentially dangerous lesions do not lead to 
tumorigenesis. Although the activation of gate-keeping 
tumor suppressor pathways has protective effects, under 
certain circumstances, they may contribute to the loss of 
tissue maintenance and drive organismal aging through 
the induction of apoptosis or senescence. Thus, a 
tenuous balance exists between aging and cancer [19-
23]. Interventions that target the gate-keeping tumor 
suppressor pathways may slow aging at the cost of 
cancer or vice versa (Figure 2).  
 
In contrast to the gate-keeping tumor suppressors, 
care-taking tumor suppressors maintain the stability of 
the genome and may simultaneously slow aging and 
prevent cancer. SIRT3 reduces oxidative stress, a 
major source of cellular and genomic damage, and 
may function as a gate-keeping tumor suppressor. 
Recently, it has been shown that deficiency of SIRT3 
promotes transformation in-vitro in mouse embryonic 



























an increased risk of carcinogenesis in the mammary 
glands. Consistent with a causal role of oxidative 
stress in tumorigenesis in the absence of SIRT3, 
SIRT3-/- MEFs and mice have higher levels of 
oxidative stress and genomic instability. The level of 
oxidative stress could be brought down by increasing 
the activity of antioxidants, which suppressed 
transformation in SIRT3-/- MEFs. Thus, SIRT3 is 
emerging as a care-taking tumor suppressor that may 




While the role of oxidative stress in determining 
lifespan is still under heated debate, mounting 
evidence suggests that oxidative stress can affect 
healthspan and lead to cancer susceptibility. 
Combating oxidative stress can potentially have 
numerous therapeutic benefits. The recent findings of 
Qiu  et al. (2010), Someya et al. (2010), Tao et al. 
(2010) and Kim et al. (2010) suggest that SIRT3 is 
involved in the cellular defense against oxidative stress 
[5,6,16,24]. SIRT3 could potentially be used to combat 
age-related decline and cancer. What remains to be 
seen is whether SIRT3 transgenic mice have extended 
lifespans and whether it is feasible to develop small 
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